BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ezekowitz JA, O'Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton PG, Heckman GA, Howlett JG, Koshman SL, Lepage S, McKelvie RS, Moe GW, Rajda M, Swiggum E, Virani SA, Zieroth S, Al-Hesayen A, Cohen-Solal A, D'Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Masoudi FA, Ross HJ, Roussin A, Sussex B. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Can J Cardiol. 2017;33:1342-1433. [PMID: 29111106 DOI: 10.1016/j.cjca.2017.08.022] [Cited by in Crossref: 284] [Cited by in F6Publishing: 292] [Article Influence: 56.8] [Reference Citation Analysis]
Number Citing Articles
1 Jarjour M, Leclerc J, Bouabdallaoui N, Ahnadi C, Brouillette D, de Denus S, Fortier A, Garceau P, Giraldeau G, Lepage S, Liszkowski M, O'Meara E, Parent MC, Racine N, Tremblay-Gravel M, White M, Rouleau JL, Ducharme A. Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes. Int J Cardiol 2022:S0167-5273(22)01408-5. [PMID: 36174819 DOI: 10.1016/j.ijcard.2022.09.058] [Reference Citation Analysis]
2 Lam AC, Tang B, Lalwani A, Verma AA, Wong BM, Razak F, Ginsburg S. Methodology paper for the General Medicine Inpatient Initiative Medical Education Database (GEMINI MedED): a retrospective cohort study of internal medicine resident case-mix, clinical care and patient outcomes. BMJ Open 2022;12:e062264. [PMID: 36153026 DOI: 10.1136/bmjopen-2022-062264] [Reference Citation Analysis]
3 Vervoort D, Jolicoeur ME, Marquis-Gravel G, Fremes SE. Is the world ready for the STICH 3.0 trial? Curr Opin Cardiol 2022. [PMID: 36094455 DOI: 10.1097/HCO.0000000000001000] [Reference Citation Analysis]
4 Chan E, Rooprai J, Rodger J, Visintini S, Rodger N, Philip S, Mielniczuk L, Sun LY. Sex-based differences in referral of heart failure patients to outpatient clinics: a scoping review. ESC Heart Fail 2022. [PMID: 36069110 DOI: 10.1002/ehf2.14143] [Reference Citation Analysis]
5 Duncker D, Bauersachs J. Current and future use of neuromodulation in heart failure. European Heart Journal Supplements 2022;24:E28-34. [DOI: 10.1093/eurheartjsupp/suac031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Arafat AA, Alawami MH, Hassan E, Alshammari A, Alfayez LA, Albabtain MA, Ismail HH, Adam AI, Pragliola C, Algarni KD. Surgical vs Transcatheter Aortic Valve Replacement in Patients With a Low Ejection Fraction. Angiology. [DOI: 10.1177/00033197221121012] [Reference Citation Analysis]
7 Di Tanna GL, Angell B, Urbich M, Lindgren P, Gaziano TA, Globe G, Stollenwerk B. A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates. Pharmacoeconomics 2022. [PMID: 35960435 DOI: 10.1007/s40273-022-01174-2] [Reference Citation Analysis]
8 Yang W, Xu Y, Gao J, Shen D, Li M, Fa J, Zhang Y, Wang R, Hou S, Hu W, Jin H, Liu Z. Effects of renal denervation therapy on cardiac function and malignant arrhythmia in patients with reduced left ventricular ejection fraction and narrow QRS complexes treated with implantable cardioverter defibrillator. Front Physiol 2022;13:938486. [DOI: 10.3389/fphys.2022.938486] [Reference Citation Analysis]
9 Chang SA, Khakh P, Janzen M, Lee T, Kiess M, Rychel V, Grewal J. Trending Cardiac Biomarkers During Pregnancy in Women With Cardiovascular Disease. Circ Heart Fail 2022;15:e009018. [PMID: 35904022 DOI: 10.1161/CIRCHEARTFAILURE.121.009018] [Reference Citation Analysis]
10 Hosseini F, Thibert MJ, Gulsin GS, Murphy D, Alexander G, Andrade JG, Hawkins NM, Laksman ZW, Yeung-lai-wah JA, Chakrabarti S, Bennett MT, Krahn AD, Deyell MW. Cardiac Magnetic Resonance in the Evaluation of Patients With Frequent Premature Ventricular Complexes. JACC: Clinical Electrophysiology 2022. [DOI: 10.1016/j.jacep.2022.06.021] [Reference Citation Analysis]
11 Tang C, Zhang J, Chen D, He J, Wang A, Feng J. Ultrasensitive label-free electrochemical immunosensor of NT-proBNP biomarker based on branched AuPd nanocrystals/N-doped honeycombed porous carbon. Bioelectrochemistry 2022. [DOI: 10.1016/j.bioelechem.2022.108225] [Reference Citation Analysis]
12 John G, Arcens M, Berra G, Garin N, Carballo D, Carballo S, Stirnemann J. Risks and benefits of urinary catheterisation during inpatient diuretic therapy for acute heart failure: a retrospective, non-inferiority, cohort study. BMJ Open 2022;12:e053632. [DOI: 10.1136/bmjopen-2021-053632] [Reference Citation Analysis]
13 Sin P, Siddiqui M, Wozniak R, Bare I, Minion J, Sanche S, Udell J, Lavoie A, Dehghani P. Heart Failure after Laboratory Confirmed Influenza Infection (FLU-HF). Global Heart 2022;17:43. [DOI: 10.5334/gh.1125] [Reference Citation Analysis]
14 Graham C, Schonnop R, Killackey T, Kavalieratos D, Bush SH, Steinberg L, Mak S, Quinn K, Isenberg SR. Exploring Health Care Providers' Experiences of Providing Collaborative Palliative Care for Patients With Advanced Heart Failure At Home: A Qualitative Study. J Am Heart Assoc 2022;:na. [PMID: 35730640 DOI: 10.1161/JAHA.121.024628] [Reference Citation Analysis]
15 Kallas D, Sandhu N, Gandilo C, Schleicher M, Banks L, Jabara M, Alberto Cerqueira Batista Filho L, Colella TJF, Connelly K, Randhawa VK. Use of Digital Health Technology in Heart Failure and Diabetes: a Scoping Review. J Cardiovasc Transl Res 2022. [PMID: 35639339 DOI: 10.1007/s12265-022-10273-6] [Reference Citation Analysis]
16 Mueller M, Siegenthaler J, Fäh D, Schuetz P. [Nutrition in Case of Heart Failure]. Praxis (Bern 1994) 2022;111:375-80. [PMID: 35611481 DOI: 10.1024/1661-8157/a003860] [Reference Citation Analysis]
17 Sepehrvand N, Islam S, Dover DC, Kaul P, McAlister FA, Armstrong PW, Ezekowitz JA. Epidemiology of worsening heart failure in a population-based cohort from Alberta, Canada: Evaluating eligibility for treatment with vericiguat. J Card Fail 2022:S1071-9164(22)00514-0. [PMID: 35589087 DOI: 10.1016/j.cardfail.2022.04.015] [Reference Citation Analysis]
18 Kataoka N, Imamura T, Koi T, Tanaka S, Fukuda N, Ueno H, Kinugawa K. Impact of S-Wave Amplitude in Right Precordial Leads on Improvement in Mitral Regurgitation following Cardiac Resynchronization Therapy. JCDD 2022;9:159. [DOI: 10.3390/jcdd9050159] [Reference Citation Analysis]
19 Hussey AJ, McKelvie RS, Ferrone M, To T, Fisk M, Singh D, Faulds C, Licskai C. Primary care-based integrated disease management for heart failure: a study protocol for a cluster randomised controlled trial. BMJ Open 2022;12:e058608. [PMID: 35551078 DOI: 10.1136/bmjopen-2021-058608] [Reference Citation Analysis]
20 Fountotos R, Munir H, Ahmad F, Goldfarb M, Afilalo J. Rationale and Design of the TARGET-EFT Trial: Multicomponent Intervention for Frail and Pre-frail Patients Hospitalized with Acute Cardiac Conditions. J Nutr Health Aging 2022;26:282-9. [PMID: 35297472 DOI: 10.1007/s12603-022-1759-y] [Reference Citation Analysis]
21 Sharma A, Verma S, Bhatt DL, Connelly KA, Swiggum E, Vaduganathan M, Zieroth S, Butler J. Optimizing Foundational Therapies in Patients With HFrEF. JACC: Basic to Translational Science 2022;7:504-17. [DOI: 10.1016/j.jacbts.2021.10.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 McBeath KCC, Angermann CE, Cowie MR. Digital Technologies to Support Better Outcome and Experience of Care in Patients with Heart Failure. Curr Heart Fail Rep 2022. [PMID: 35486314 DOI: 10.1007/s11897-022-00548-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Strangl F, Ischanow E, Ullrich A, Oechsle K, Fluschnik N, Magnussen C, Knappe D, Grahn H, Blankenberg S, Bokemeyer C, Kirchhof P, Rybczynski M. Symptom burden, psychosocial distress and palliative care needs in heart failure - A cross-sectional explorative pilot study. Clin Res Cardiol 2022. [PMID: 35420358 DOI: 10.1007/s00392-022-02017-y] [Reference Citation Analysis]
24 Kerov A, Meier A, Wigger O, Linka A. [CME: Heart Failure- Overview, Clinical Manifestation, Diagnosis and Management]. Praxis (Bern 1994) 2022;111:260-9. [PMID: 35414248 DOI: 10.1024/1661-8157/a003871] [Reference Citation Analysis]
25 Stein C, Helal L, Migliavaca CB, Sangalli CN, Colpani V, Raupp da Rosa P, Beck-da-silva L, Rohde LE, Polanczyk CA, Falavigna M. Are the recommendation of sodium and fluid restriction in heart failure patients changing over the past years? A systematic review and meta-analysis. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.03.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Parry M, Van Spall HG, Mullen K, Mulvagh SL, Pacheco C, Colella TJ, Clavel M, Jaffer S, Foulds HJ, Grewal J, Hardy M, Price JA, Levinsson AL, Gonsalves CA, Norris CM. The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women-Chapter 6: Sex- And Gender-Specific Diagnosis and Treatment. CJC Open 2022. [DOI: 10.1016/j.cjco.2022.04.002] [Reference Citation Analysis]
27 Poon S, Rojas-fernandez C, Virani S, Honos G, Mckelvie R. The Canadian Heart Failure (CAN-HF) Registry: A Canadian multi-centre, retrospective study of inpatients with heart failure. CJC Open 2022. [DOI: 10.1016/j.cjco.2022.04.005] [Reference Citation Analysis]
28 Shirakabe A, Okazaki H, Matsushita M, Shibata Y, Shigihara S, Nishigoori S, Sawatani T, Sasamoto N, Kiuchi K, Atsukawa M, Itokawa N, Arai T, Kobayashi N, Asai K. Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure. ESC Heart Fail 2022. [PMID: 35289118 DOI: 10.1002/ehf2.13878] [Reference Citation Analysis]
29 Miller RJH, Nabipoor M, Youngson E, Kotrri G, Fine NM, Howlett JG, Paterson ID, Ezekowitz J, McAlister FA. Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk. ESC Heart Fail 2022. [PMID: 35261203 DOI: 10.1002/ehf2.13869] [Reference Citation Analysis]
30 El Hussein MT, Negash S. Cluster Scheme Approach to Foundational Heart Failure With Reduced Ejection Fraction Therapy. The Journal for Nurse Practitioners 2022. [DOI: 10.1016/j.nurpra.2022.02.009] [Reference Citation Analysis]
31 Wolfe A, Watt CL, Downar J, Bush SH. Use and Discontinuation of Milrinone for Advanced Heart Failure in an Academic Palliative Care Unit: A Case Report and Discussion of Recommendations. J Pain Palliat Care Pharmacother 2022;36:24-33. [PMID: 35234559 DOI: 10.1080/15360288.2022.2027058] [Reference Citation Analysis]
32 Patrick M, Miller B, Will B, Bena JF, Morrison SL, Siegmund LA. Anxiety and depression moderate the relationship between quality of life and self-care in patients with heart failure. Geriatric Nursing 2022;44:54-9. [DOI: 10.1016/j.gerinurse.2021.12.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Steinberg L, Isenberg SR, Mak S, Meaney C, Lokuge B, Arvanitis J, Goldman R, Wegier P, Husain AF. HeartFull: Feasibility of an Integrated Program of Care for Patients with Advanced Stage of Heart Failure. Am J Hosp Palliat Care 2022;:10499091211069626. [PMID: 35128951 DOI: 10.1177/10499091211069626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Henkens MTHM, Weerts J, Verdonschot JAJ, Raafs AG, Stroeks S, Sikking MA, Amin H, Mourmans SGJ, Geraeds CBG, Sanders-van Wijk S, Barandiarán Aizpurua A, Uszko-Lencer NHMK, Krapels IPC, Wolffs PFG, Brunner HG, van Leeuwen REW, Verhesen W, Schalla SM, van Stipdonk AWM, Knackstedt C, Li X, Abdul Hamid MA, van Paassen P, Hazebroek MR, Vernooy K, Brunner-La Rocca HP, van Empel VPM, Heymans SRB. Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry. ESC Heart Fail 2022. [PMID: 35118823 DOI: 10.1002/ehf2.13833] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ware P, Shah A, Ross HJ, Logan AG, Segal P, Cafazzo JA, Szacun-Shimizu K, Resnick M, Vattaparambil T, Seto E. Challenges of Telemonitoring Programs for Complex Chronic Conditions: Randomized Controlled Trial With an Embedded Qualitative Study. J Med Internet Res 2022;24:e31754. [PMID: 35080502 DOI: 10.2196/31754] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Damy T, Benedyga V, Pezel T, Berthelot E, Gauthier J, Habib G, Iliou MC, Aupetit JF, Baudry G, De Groote P, Logeart D, Chaufourier L, Ciobotaru V, Pousset F, Beauvais F, Bauer F, Zores F, Lairez O, Richard K, Hittinger L, Teiger E, Taieb C, Audureau E. Prescription, Compliance, and Burden Associated with Salt-Restricted Diets in Heart Failure Patients: Results from the French National OFICSel Observatory. Nutrients 2022;14:308. [PMID: 35057490 DOI: 10.3390/nu14020308] [Reference Citation Analysis]
37 Campeau Calfat A, Simard M, Ouali A, Blais C, Sirois C. Polypharmacy among older individuals with heart failure: trends between 2000 and 2017 in the province of Quebec, Canada. Ther Adv Cardiovasc Dis 2022;16:17539447221113946. [PMID: 35875931 DOI: 10.1177/17539447221113946] [Reference Citation Analysis]
38 Liu X, Wu R, Lai L, Lin J. Clinical application of High-flow nasal cannula oxygen therapy in acute heart failure. Food Sci Technol 2022;42:e40020. [DOI: 10.1590/fst.40020] [Reference Citation Analysis]
39 Chang SA, Yim J, Yeung DF, Gin K, Jue J, Nair P, Tsang MYC, Kelliher E, Tsang TSM. Relationship between enlarged cardiac silhouette on chest X-ray and left ventricular size on transthoracic echocardiography. Int J Cardiovasc Imaging 2021. [PMID: 34966961 DOI: 10.1007/s10554-021-02465-z] [Reference Citation Analysis]
40 Tajabadi M, Goran Orimi H, Ramzgouyan MR, Nemati A, Deravi N, Beheshtizadeh N, Azami M. Regenerative strategies for the consequences of myocardial infarction: Chronological indication and upcoming visions. Biomed Pharmacother 2021;146:112584. [PMID: 34968921 DOI: 10.1016/j.biopha.2021.112584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Sharma BPharm V, Kulkarni V, McAlister F, Eurich D, Keshwani S, Simpson SH, Voaklander D, Samanani S. Predicting 30-day readmissions in patients with heart failure using administrative data: a machine learning approach. J Card Fail 2021:S1071-9164(21)00499-1. [PMID: 34936894 DOI: 10.1016/j.cardfail.2021.12.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Arenas Ochoa LF, González-Jaramillo V, Saldarriaga C, Lemos M, Krikorian A, Vargas JJ, Gómez-Batiste X, Gonzalez-Jaramillo N, Eychmüller S. Prevalence and characteristics of patients with heart failure needing palliative care. BMC Palliat Care 2021;20:184. [PMID: 34856953 DOI: 10.1186/s12904-021-00850-y] [Reference Citation Analysis]
43 Yao F, Zhang Y, Kuang X, Zhou Q, Huang L, Peng J, Hou K, Du S. Effects of Cardiac Rehabilitation Training in Patients with Heart Failure Based on Traditional Chinese Exercise: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2021;2021:1068623. [PMID: 34819979 DOI: 10.1155/2021/1068623] [Reference Citation Analysis]
44 Elserafy AS, Reda A, Farag E, Mostafa T, Farag N, Elbahry A, Sanad O, Bendary A, Elkersh A, Attia I, Selim M, Khamis H, Issak ER. Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction. Clin Drug Investig 2021;41:1027-36. [PMID: 34780022 DOI: 10.1007/s40261-021-01095-6] [Reference Citation Analysis]
45 Bews H, Saeed M, Liu S. Peripartum cardiomyopathy. CMAJ 2021;193:E1733. [PMID: 34782377 DOI: 10.1503/cmaj.210468] [Reference Citation Analysis]
46 Cinq-Mars A, Massot M, Belzile D, Turgeon PY, Dubois-Sénéchal SM, Laliberté C, Komlosy MÈ, Leblanc MH, Bergeron S, O'Connor K, Morin J, Bourgault C, Bernier M, Beaudoin J, Radermaker S, Laflamme M, Charbonneau E, Sénéchal M. Heavy burden of toxic dilated cardiomyopathy among young adults: A retrospective study and review of the literature. Can J Cardiol 2021:S0828-282X(21)00823-0. [PMID: 34774720 DOI: 10.1016/j.cjca.2021.11.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Avagimyan AA, Mkrtchyan LH, Gevorkyan AA, Kononchuk NB, Kakturskiy LV, Djndoyan ZT. Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:785-91. [DOI: 10.20996/1819-6446-2021-10-17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Pacheco C, Mullen K, Coutinho T, Jaffer S, Parry M, Van Spall HG, Clavel M, Edwards JD, Sedlak T, Norris CM, Dhukai A, Grewal J, Mulvagh SL. THE CANADIAN WOMEN’S HEART HEALTH ALLIANCE ATLAS ON THE EPIDEMIOLOGY, DIAGNOSIS, AND MANAGEMENT OF CARDIOVASCULAR DISEASE IN WOMEN -- CHAPTER 5: SEX- AND GENDER-UNIQUE MANIFESTATIONS OF CARDIOVASCULAR DISEASE. CJC Open 2021. [DOI: 10.1016/j.cjco.2021.11.006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Cheng XR, Guan LJ, Muskat MN, Cao CC, Guan B. Effects of Ejiao peptide-iron chelates on intestinal inflammation and gut microbiota in iron deficiency anemic mice. Food Funct 2021;12:10887-902. [PMID: 34643632 DOI: 10.1039/d1fo01802g] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Zhang Q, Kang Y, Tang S, Yu CM. Intersection Between Diabetes and Heart Failure: Is SGLT2i the "One Stone for Two Birds" Approach? Curr Cardiol Rep 2021;23:171. [PMID: 34647188 DOI: 10.1007/s11886-021-01591-3] [Reference Citation Analysis]
51 Lee DS, Straus SE, Austin PC, Mohamed S, Taljaard M, Chong A, Fang J, Prasad T, Farkouh ME, Schull MJ, Mak S, Ross HJ. Rationale and design of the comparison of outcomes and access to care for heart failure (COACH) trial: A stepped wedge cluster randomized trial. Am Heart J 2021;240:1-10. [PMID: 33984316 DOI: 10.1016/j.ahj.2021.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Le N, Rahman T, Kapralik JL, Ibrahim Q, Lear SA, Van Spall HG. The Hospital at Home Model vs Routine Hospitalization for Acute Heart Failure: A Survey of Patients’ Preferences. CJC Open 2021. [DOI: 10.1016/j.cjco.2021.10.005] [Reference Citation Analysis]
53 Sweeney C, Pharithi RB, Kerr B, Ryan C, Ryan F, Collins L, Halley C, Barrett M, Watson CJ, McDonald K, Ledwidge M. NT-proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme. ESC Heart Fail 2021. [PMID: 34586748 DOI: 10.1002/ehf2.13576] [Reference Citation Analysis]
54 Bohn MK, Adeli K. Physiological and metabolic adaptations in pregnancy: importance of trimester-specific reference intervals to investigate maternal health and complications. Crit Rev Clin Lab Sci 2021;:1-17. [PMID: 34587857 DOI: 10.1080/10408363.2021.1978923] [Reference Citation Analysis]
55 Woodhouse DC, Frolkis AD, Murray BJ, Solbak NM, Samardzic N, Burak KW. The Impact of Comorbidities on Calgary Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease and Heart Failure. Cureus 2021;13:e17303. [PMID: 34552837 DOI: 10.7759/cureus.17303] [Reference Citation Analysis]
56 Kidson KM, Lapinsky S, Grewal J. A Detailed Review of Critical Care Considerations for the Pregnant Cardiac Patient. Can J Cardiol 2021:S0828-282X(21)00665-6. [PMID: 34534620 DOI: 10.1016/j.cjca.2021.08.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 O'Neill DE, Forman DE. Cardiovascular care of older adults. BMJ 2021;374:n1593. [PMID: 34465575 DOI: 10.1136/bmj.n1593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
58 Tost J, Llorens P, Cotter G, Davison B, Jacob J, Gil V, Herrero P, Martín-Sánchez FJ, Donea R, Rodríguez B, Lucas-Imbernon FJ, Andueza JA, Mecina AB, Torres-Gárate R, Piñera P, Alquézar-Arbé A, Espinosa B, Mebazaa A, Chioncel O, Miró Ò; ICA-SEMES group. Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation. Eur J Intern Med 2021;94:73-84. [PMID: 34446316 DOI: 10.1016/j.ejim.2021.07.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Waranugraha Y, Rohman MS, Setiawan D, Aziz IJ. Aggressive beta-blocker titration in stabilized acute heart failure patients with low left ventricular ejection fraction. J Taibah Univ Med Sci 2021;16:582-90. [PMID: 34408616 DOI: 10.1016/j.jtumed.2021.02.012] [Reference Citation Analysis]
60 Di Santo P, Mathew R, Jung RG, Simard T, Skanes S, Mao B, Ramirez FD, Marbach JA, Abdel-Razek O, Motazedian P, Parlow S, Boczar KE, D'Egidio G, Hawken S, Bernick J, Wells GA, Dick A, So DY, Glover C, Russo JJ, McGuinty C, Hibbert B; CAPITAL DOREMI investigators. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial. Crit Care 2021;25:289. [PMID: 34376218 DOI: 10.1186/s13054-021-03706-2] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
61 Kataoka N, Imamura T, Koi T, Uchida K, Kinugawa K. A Simple Predictive Marker in Cardiac Resynchronization Therapy Recipients: Prominent S-Wave in Right Precordial Leads. Medicina (Kaunas) 2021;57:815. [PMID: 34441021 DOI: 10.3390/medicina57080815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Douglass EJ, Blauwet LA. Peripartum Cardiomyopathy. Cardiol Clin 2021;39:119-42. [PMID: 33222808 DOI: 10.1016/j.ccl.2020.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Ambrosy AP, von Haehling S, Kalra PR, Court E, Bhandari S, McDonagh T, Cleland JGF. Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure. Am J Cardiol 2021;152:138-45. [PMID: 34162484 DOI: 10.1016/j.amjcard.2021.04.042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Berei T, Forsyth P, Balakumaran K, Harshaw-Ellis K, Koshman S, Rasmusson K. Implementing Nonphysician Provider Guideline-Directed Medical Therapy Heart Failure Clinics: A Multi-National Imperative. J Card Fail 2021;27:896-906. [PMID: 34364666 DOI: 10.1016/j.cardfail.2021.06.001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
65 Kosyakovsky LB, Austin PC, Ross HJ, Wang X, Abdel-Qadir H, Goodman SG, Farkouh ME, Croxford R, Lawler PR, Spertus JA, Lee DS. Early invasive coronary angiography and acute ischaemic heart failure outcomes. Eur Heart J 2021:ehab423. [PMID: 34331056 DOI: 10.1093/eurheartj/ehab423] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
66 Koops J. Machine Learning in an Elderly Man with Heart Failure. Int Med Case Rep J 2021;14:497-502. [PMID: 34349566 DOI: 10.2147/IMCRJ.S322827] [Reference Citation Analysis]
67 Sopek Merkaš I, Slišković AM, Lakušić N. Current concept in the diagnosis, treatment and rehabilitation of patients with congestive heart failure. World J Cardiol 2021; 13(7): 183-203 [PMID: 34367503 DOI: 10.4330/wjc.v13.i7.183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
68 Heckman GA, Hirdes JP, Hébert P, Costa A, Onder G, Declercq A, Nova A, Chen J, McKelvie RS. Assessments of heart failure and frailty-related health instability provide complementary and useful information for home care planning and prognosis. Can J Cardiol 2021:S0828-282X(21)00374-3. [PMID: 34303783 DOI: 10.1016/j.cjca.2021.07.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
69 Saposnik G, Saposnik F, Saposnik P. Rethinking adherence to home care in heart failure: the lessons learned from Diego Maradona's death. Home Health Care Serv Q 2021;:1-12. [PMID: 34284687 DOI: 10.1080/01621424.2021.1945519] [Reference Citation Analysis]
70 de Waard D, Fagan A, Minnaar C, Horne D. Prise en charge des patients après un pontage aortocoronarien: guide pour les professionnels en soins primaires. CMAJ 2021;193:E1107-13. [PMID: 34281973 DOI: 10.1503/cmaj.191108-f] [Reference Citation Analysis]
71 Floras JS. The 2021 Carl Ludwig Lecture. Unsympathetic autonomic regulation in heart failure: patient-inspired insights. Am J Physiol Regul Integr Comp Physiol 2021;321:R338-51. [PMID: 34259047 DOI: 10.1152/ajpregu.00143.2021] [Reference Citation Analysis]
72 Yu Y, Yao RQ, Zhang YF, Wang SY, Xi W, Wang JN, Huang XY, Yao YM, Wang ZN. Is oxygen therapy beneficial for normoxemic patients with acute heart failure? A propensity score matched study. Mil Med Res 2021;8:38. [PMID: 34238369 DOI: 10.1186/s40779-021-00330-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Khan MS, Khan F, Fonarow GC, Sreenivasan J, Greene SJ, Khan SU, Usman MS, Vaduganathan M, Fudim M, Anker SD, Butler J. Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map. Eur J Heart Fail 2021. [PMID: 34173307 DOI: 10.1002/ejhf.2278] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
74 Krüger C, Schäfer I, van den Bussche H, Baehr M, Bickel H, Fuchs A, Gensichen J, Maier W, Riedel-Heller SG, König HH, Dahlhaus A, Schön G, Weyerer S, Wiese B, von Renteln-Kruse W, Langebrake C, Scherer M. Non-random relations in drug use expressed as patterns comprising prescription and over-the-counter drugs in multimorbid elderly patients in primary care: Data of the exploratory analysis of the multicentre, observational cohort study MultiCare. Eur J Gen Pract 2021;27:119-29. [PMID: 34132623 DOI: 10.1080/13814788.2021.1933425] [Reference Citation Analysis]
75 Bohn MK, Steele S, Hall A, Poonia J, Jung B, Adeli K. Cardiac Biomarkers in Pediatrics: An Undervalued Resource. Clin Chem 2021;67:947-58. [PMID: 34125147 DOI: 10.1093/clinchem/hvab063] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
76 Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, Usui A, Okishige K, Kusano K, Kumagai K, Goya M, Kobayashi Y, Shimizu A, Shimizu W, Shoda M, Sumitomo N, Seo Y, Takahashi A, Tada H, Naito S, Nakazato Y, Nishimura T, Nitta T, Niwano S, Hagiwara N, Murakawa Y, Yamane T, Aiba T, Inoue K, Iwasaki Y, Inden Y, Uno K, Ogano M, Kimura M, Sakamoto SI, Sasaki S, Satomi K, Shiga T, Suzuki T, Sekiguchi Y, Soejima K, Takagi M, Chinushi M, Nishi N, Noda T, Hachiya H, Mitsuno M, Mitsuhashi T, Miyauchi Y, Miyazaki A, Morimoto T, Yamasaki H, Aizawa Y, Ohe T, Kimura T, Tanemoto K, Tsutsui H, Mitamura H; JCS/JHRS Joint Working Group. JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. J Arrhythm 2021;37:709-870. [PMID: 34386109 DOI: 10.1002/joa3.12491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
77 Senarath S, Fernie G, Roshan Fekr A. Influential Factors in Remote Monitoring of Heart Failure Patients: A Review of the Literature and Direction for Future Research. Sensors (Basel) 2021;21:3575. [PMID: 34063825 DOI: 10.3390/s21113575] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Mentz RJ, Ambrosy AP, Ezekowitz JA, Lewis GD, Butler J, Wong YW, De Pasquale CG, Troughton RW, O'Meara E, Rockhold FW, Garg J, Samsky MD, Leloudis D, Dugan M, Mundy LM, Hernandez AF; HEART-FID Trial Investigators. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design. Circ Heart Fail 2021;14:e008100. [PMID: 34003690 DOI: 10.1161/CIRCHEARTFAILURE.120.008100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
79 Ahmad T, Yamamoto Y, Biswas A, Ghazi L, Martin M, Simonov M, Hsiao A, Kashyap N, Velazquez EJ, Desai NR, Wilson FP. REVeAL-HF: Design and Rationale of a Pragmatic Randomized Controlled Trial Embedded Within Routine Clinical Practice. JACC Heart Fail 2021;9:409-19. [PMID: 33992566 DOI: 10.1016/j.jchf.2021.03.006] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
80 de Waard D, Fagan A, Minnaar C, Horne D. Management of patients after coronary artery bypass grafting surgery: a guide for primary care practitioners. CMAJ 2021;193:E689-94. [PMID: 33972222 DOI: 10.1503/cmaj.191108] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
81 Crosier R, Austin PC, Ko DT, Lawler PR, Stukel TA, Farkouh ME, Wang X, Spertus JA, Ross HJ, Lee DS. Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes. Am J Med 2021;134:672-681.e4. [PMID: 33181105 DOI: 10.1016/j.amjmed.2020.10.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-lundqvist C, Boriani G, Castella M, Dan G, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, Meir ML, Lane DA, Lebeau J, Lettino M, Lip GY, Pinto FJ, Neil Thomas G, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL. Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS). Revista Española de Cardiología 2021;74:437.e1-437.e116. [DOI: 10.1016/j.recesp.2020.10.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
83 Johansson I, Joseph P, Balasubramanian K, McMurray JJV, Lund LH, Ezekowitz JA, Kamath D, Alhabib K, Bayes-Genis A, Budaj A, Dans ALL, Dzudie A, Probstfield JL, Fox KAA, Karaye KM, Makubi A, Fukakusa B, Teo K, Temizhan A, Wittlinger T, Maggioni AP, Lanas F, Lopez-Jaramillo P, Silva-Cardoso J, Sliwa K, Dokainish H, Grinvalds A, McCready T, Yusuf S; G-CHF Investigators. Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries. Circulation 2021;143:2129-42. [PMID: 33906372 DOI: 10.1161/CIRCULATIONAHA.120.050850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
84 Vijh R, Wong ST, Grandy M, Peterson S, Ezzat AM, Gibb AG, Hawkins NM. Identifying heart failure in patients with chronic obstructive lung disease through the Canadian Primary Care Sentinel Surveillance Network in British Columbia: a case derivation study. CMAJ Open 2021;9:E376-83. [PMID: 33863795 DOI: 10.9778/cmajo.20200183] [Reference Citation Analysis]
85 Mousavi Movahed SM, Akhavizadegan H, Dolatkhani F, Nejadghaderi SA, Aghajani F, Faghir Gangi M, Ghazi Z, Ghasemi H. Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study. J Med Virol 2021;93:4411-9. [PMID: 33792956 DOI: 10.1002/jmv.26992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
86 Jiang Y, Wang W. Improve self-care in heart failure. Int J Nurs Sci 2021;8:243-4. [PMID: 33997141 DOI: 10.1016/j.ijnss.2021.01.001] [Reference Citation Analysis]
87 Lee T, Cau A, Cheng MP, Levin A, Lee TC, Vinh DC, Lamontagne F, Singer J, Walley KR, Murthy S, Patrick D, Rewa OG, Winston BW, Marshall J, Boyd J, Tran K, Kalil AC, Mcculoh R, Fowler R, Luther JM, Russell JA; ARBs CORONA. Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors. CJC Open 2021;3:965-75. [PMID: 33842874 DOI: 10.1016/j.cjco.2021.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
88 Wongtanasarasin W, Siri-Angkul N, Wittayachamnankul B, Chattipakorn SC, Chattipakorn N. Mitochondrial dysfunction in fatal ventricular arrhythmias. Acta Physiol (Oxf) 2021;231:e13624. [PMID: 33555138 DOI: 10.1111/apha.13624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
89 Rai D, Waheed SH, Guerriero M, Tahir MW, Pandey R, Patel H, Thakkar S, Mulvagh SL, Bastiany A, Zieroth S, Norris CM, Van Spall HG, Michos ED, Gulati M. National Trends of Gender Disparity in Canadian Cardiovascular Society Guideline Authors, 2001-2020. CJC Open 2021. [DOI: 10.1016/j.cjco.2021.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Parkash R, Wells G, Rouleau J, Talajic M, Essebag V, Skanes A, Wilton SB, Verma A, Healey JS, Tang AS. A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design. Am Heart J 2021;234:90-100. [PMID: 33472052 DOI: 10.1016/j.ahj.2021.01.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
91 McDonald M, Virani S, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk L, Moe GW, O'Meara E, Swiggum E, Toma M, Zieroth S, Anderson K, Bray SA, Clarke B, Cohen-Solal A, D'Astous M, Davis M, De S, Grant ADM, Grzeslo A, Heshka J, Keen S, Kouz S, Lee D, Masoudi FA, McKelvie R, Parent MC, Poon S, Rajda M, Sharma A, Siatecki K, Storm K, Sussex B, Van Spall H, Yip AMC. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction. Can J Cardiol 2021;37:531-46. [PMID: 33827756 DOI: 10.1016/j.cjca.2021.01.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 52] [Article Influence: 11.0] [Reference Citation Analysis]
92 Gupta M, Bell A, Padarath M, Ngui D, Ezekowitz J. Physician Perspectives on the Diagnosis and Management of Heart Failure With Preserved Ejection Fraction. CJC Open 2021;3:361-6. [PMID: 33778453 DOI: 10.1016/j.cjco.2020.11.008] [Reference Citation Analysis]
93 Xie C, Qi H, Huan L, Yang Y. Effect of miR-195-5p on cardiomyocyte apoptosis in rats with heart failure by regulating TGF-β1/Smad3 signaling pathway. Biosci Rep 2020;40:BSR20200566. [PMID: 32329515 DOI: 10.1042/BSR20200566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
94 Turgeon RD, Barry AR, Hawkins NM, Ellis UM. Pharmacotherapy for heart failure with reduced ejection fraction and health-related quality of life: a systematic review and meta-analysis. Eur J Heart Fail 2021;23:578-89. [PMID: 33634543 DOI: 10.1002/ejhf.2141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
95 Adams SJ, Haddad H. Artificial Intelligence to Diagnose Heart Failure Based on Chest X-Rays and Potential Clinical Implications. Can J Cardiol 2021;37:1153-5. [PMID: 33667617 DOI: 10.1016/j.cjca.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
96 Beldhuis IE, Myhre PL, Bristow M, Claggett B, Damman K, Fang JC, Fleg JL, McKinlay S, Lewis EF, O'Meara E, Pitt B, Shah SJ, Vardeny O, Voors AA, Pfeffer MA, Solomon SD, Desai AS. Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function. J Am Coll Cardiol 2021;77:1211-21. [PMID: 33663739 DOI: 10.1016/j.jacc.2020.12.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Procopio MC, Lauro R, Nasso C, Carerj S, Squadrito F, Bitto A, Di Bella G, Micari A, Irrera N, Costa F. Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways. Biomedicines 2021;9:204. [PMID: 33670488 DOI: 10.3390/biomedicines9020204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
98 Hirata Y, Kusunose K, Tsuji T, Fujimori K, Kotoku J, Sata M. Deep Learning for Detection of Elevated Pulmonary Artery Wedge Pressure Using Standard Chest X-Ray. Can J Cardiol 2021;37:1198-206. [PMID: 33609716 DOI: 10.1016/j.cjca.2021.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
99 Ishikawa Y, Sattler ELP. Nutrition as Treatment Modality in Heart Failure. Curr Atheroscler Rep 2021;23:13. [PMID: 33594492 DOI: 10.1007/s11883-021-00908-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
100 Patti A, Merlo L, Ambrosetti M, Sarto P. Exercise-Based Cardiac Rehabilitation Programs in Heart Failure Patients. Heart Fail Clin 2021;17:263-71. [PMID: 33673950 DOI: 10.1016/j.hfc.2021.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
101 Wong JA, Roberts JD, Healey JS. The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape. Can J Cardiol 2021;37:644-54. [PMID: 33549824 DOI: 10.1016/j.cjca.2021.01.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
102 Carbonneau M, Davyduke T, Congly SE, Ma MM, Newnham K, Den Heyer V, Tandon P, Abraldes JG. Impact of specialized multidisciplinary care on cirrhosis outcomes and acute care utilization. CanLivJ 2021;4:38-50. [DOI: 10.3138/canlivj-2020-0017] [Reference Citation Analysis]
103 Noly PE, Carrier M. Commentary: Coronary artery bypass grafting surgery alone is not the only way! J Thorac Cardiovasc Surg 2021:S0022-5223(21)00166-5. [PMID: 33610363 DOI: 10.1016/j.jtcvs.2021.01.067] [Reference Citation Analysis]
104 Davis MK, Fine NM, Small GR, Connolly K, Bosley D, Zieroth S, Virani SA. Establishing a Cardiac Amyloidosis Clinic: A Practical Primer for Cardiologists. Can J Cardiol 2021;37:674-8. [PMID: 33485855 DOI: 10.1016/j.cjca.2021.01.015] [Reference Citation Analysis]
105 Almazroa L, Mihajlovic V, Lawler PR, Luk A. Crossing the chasm: caution for use of angiotensin receptor-neprilysin inhibition in patients with cardiogenic shock- a case report. Eur Heart J Case Rep 2020;4:1-4. [PMID: 33442637 DOI: 10.1093/ehjcr/ytaa233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
106 Miller RJH, Howlett JG, Fine NM. A Novel Approach to Medical Management of Heart Failure With Reduced Ejection Fraction. Can J Cardiol 2021;37:632-43. [PMID: 33453357 DOI: 10.1016/j.cjca.2020.12.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
107 Gupta AK, Tomasoni D, Sidhu K, Metra M, Ezekowitz JA. Evidence-Based Management of Acute Heart Failure. Can J Cardiol 2021;37:621-31. [PMID: 33440229 DOI: 10.1016/j.cjca.2021.01.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
108 Douglass EJ, Cooper LT Jr, Morales-Lara AC, Adedinsewo DA, Rozen TD, Blauwet LA, Fairweather D. A Case-Control Study of Peripartum Cardiomyopathy Using the Rochester Epidemiology Project. J Card Fail 2021;27:132-42. [PMID: 33388468 DOI: 10.1016/j.cardfail.2020.12.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 McGuinty C, Downar J, Slawnych M. Shared Decision Making and Effective Communication in Heart Failure-Moving from "Code Status" to Decisional Readiness. Can J Cardiol 2021;37:665-8. [PMID: 33373725 DOI: 10.1016/j.cjca.2020.11.019] [Reference Citation Analysis]
110 Patel Y, Joseph J. Sodium Intake and Heart Failure. Int J Mol Sci 2020;21:E9474. [PMID: 33322108 DOI: 10.3390/ijms21249474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
111 Bobčíková K, Bužgová R. (Interventions in Care of Patients with Heart Failure for Improvement of Quality of Life). Cor Vasa 2020;62:588-94. [DOI: 10.33678/cor.2020.038] [Reference Citation Analysis]
112 Badrov MB, Mak S, Floras JS. Cardiovascular Autonomic Disturbances in Heart Failure With Preserved Ejection Fraction. Can J Cardiol 2021;37:609-20. [PMID: 33310140 DOI: 10.1016/j.cjca.2020.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
113 Bonares MJ, Mah K, MacIver J, Hurlburt L, Kaya E, Rodin G, Ross H, Zimmermann C, Wentlandt K. Referral Practices of Cardiologists to Specialist Palliative Care in Canada. CJC Open 2021;3:460-9. [PMID: 34027349 DOI: 10.1016/j.cjco.2020.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
114 Volpe M, Bauersachs J, Bayés-Genís A, Butler J, Cohen-Solal A, Gallo G, Deichl AS, Khan MS, Battistoni A, Pieske B, Saito Y, Zieroth S. Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence. Int J Cardiol 2021;327:138-45. [PMID: 33301829 DOI: 10.1016/j.ijcard.2020.11.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
115 Russell JA, Marshall JC, Slutsky A, Murthy S, Sweet D, Lee T, Singer J, Patrick DM, Du B, Peng Z, Cheng M, Burns KD, Harhay MO. Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection. BMJ Open 2020;10:e040768. [PMID: 33293316 DOI: 10.1136/bmjopen-2020-040768] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
116 Boulet J, Massie E, Rouleau JL. Heart Failure With Midrange Ejection Fraction-What Is It, If Anything? Can J Cardiol 2021;37:585-94. [PMID: 33276048 DOI: 10.1016/j.cjca.2020.11.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Xu L, Pagano JJ, Haykowksy MJ, Ezekowitz JA, Oudit GY, Mikami Y, Howarth A, White JA, Dyck JRB, Anderson T, Paterson DI, Thompson RB; AB HEART Investigators. Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance: not all layers are the same. J Cardiovasc Magn Reson 2020;22:81. [PMID: 33267877 DOI: 10.1186/s12968-020-00680-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
118 Randhawa VK, Dhanvantari S, Connelly KA. How Diabetes and Heart Failure Modulate Each Other and Condition Management. Can J Cardiol 2021;37:595-608. [PMID: 33276047 DOI: 10.1016/j.cjca.2020.11.014] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
119 Kiamanesh O, Toma M. The State of the Heart Biopsy: A Clinical Review. CJC Open 2021;3:524-31. [PMID: 34027357 DOI: 10.1016/j.cjco.2020.11.017] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
120 Lee S, Ban TH, Park HS, Seo SM, Chung BH, Lim J, Oh EJ, Choi B, Park CW, Yang CW, Baek SH, Kim YS. Role of Renal Replacement Therapy During the Peri-Transplant Period of Heart Transplantation. Ann Transplant 2020;25:e925648. [PMID: 33230094 DOI: 10.12659/AOT.925648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Lee F, Mielniczuk LM. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management. Can J Cardiol 2021;37:572-84. [PMID: 33217522 DOI: 10.1016/j.cjca.2020.11.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Lau K, Malik A, Foroutan F, Buchan TA, Daza JF, Sekercioglu N, Orchanian-Cheff A, Alba AC. Resting Heart Rate as an Important Predictor of Mortality and Morbidity in Ambulatory Patients With Heart Failure: A Systematic Review and Meta-Analysis. J Card Fail 2021;27:349-63. [PMID: 33171294 DOI: 10.1016/j.cardfail.2020.11.003] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
123 Benstoem C, Kalvelage C, Breuer T, Heussen N, Marx G, Stoppe C, Brandenburg V. Ivabradine as adjuvant treatment for chronic heart failure. Cochrane Database Syst Rev 2020;11:CD013004. [PMID: 33147368 DOI: 10.1002/14651858.CD013004.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Artanian V, Ross HJ, Rac VE, O'Sullivan M, Brahmbhatt DH, Seto E. Impact of Remote Titration Combined With Telemonitoring on the Optimization of Guideline-Directed Medical Therapy for Patients With Heart Failure: Internal Pilot of a Randomized Controlled Trial. JMIR Cardio 2020;4:e21962. [PMID: 33141094 DOI: 10.2196/21962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Phan Thai H, Hoang Bui B, Hoang Anh T, Huynh Van M. Value of Plasma NGAL and Creatinine on First Day of Admission in the Diagnosis of Cardiorenal Syndrome Type 1. Cardiol Res Pract 2020;2020:2789410. [PMID: 33083054 DOI: 10.1155/2020/2789410] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
126 Gaudino M, Hameed I, Khan FM, Tam DY, Rahouma M, Yongle R, Naik A, Di Franco A, Demetres M, Petrie MC, Jolicoeur EM, Girardi LN, Fremes SE. Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis. European Journal of Cardio-Thoracic Surgery 2021;59:293-301. [DOI: 10.1093/ejcts/ezaa319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
127 Artanian V, Rac VE, Ross HJ, Seto E. Impact of Remote Titration Combined With Telemonitoring on the Optimization of Guideline-Directed Medical Therapy for Patients With Heart Failure: Protocol for a Randomized Controlled Trial. JMIR Res Protoc 2020;9:e19705. [PMID: 33048057 DOI: 10.2196/19705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
128 Numan S, Kaluza K. Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications. Curr Med Res Opin 2020;36:1769-82. [PMID: 32936683 DOI: 10.1080/03007995.2020.1824898] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
129 Fitchett DH, Leiter LA, Lin P, Pickering J, Welsh R, Stone J, Gregoire J, McFarlane P, Langer A, Gupta A, Goodman SG. Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome. CJC Open 2020;2:402-15. [PMID: 32995726 DOI: 10.1016/j.cjco.2020.04.002] [Reference Citation Analysis]
130 Huitema AA, Daoust A, Anderson K, Poon S, Virani S, White M, Rojas-Fernandez C, Zieroth S, McKelvie RS. Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada. CJC Open 2020;2:321-7. [PMID: 32995716 DOI: 10.1016/j.cjco.2020.03.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
131 Ouyang M, Tu D, Tong L, Sarwar M, Bhimaraj A, Li C, Coté GL, Di Carlo D. A review of biosensor technologies for blood biomarkers toward monitoring cardiovascular diseases at the point-of-care. Biosens Bioelectron 2021;171:112621. [PMID: 33120234 DOI: 10.1016/j.bios.2020.112621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
132 El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS. Potentially Inappropriate Prescriptions in Heart Failure with Reduced Ejection Fraction (PIP-HFrEF). Eur Heart J Cardiovasc Pharmacother 2020:pvaa108. [PMID: 32941594 DOI: 10.1093/ehjcvp/pvaa108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
133 Yanicelli LM, Vegetti M, Goy CB, Martínez EC, Herrera MC. SiTe iC: A telemonitoring system for heart failure patients. Int J Med Inform 2020;141:104204. [PMID: 32593010 DOI: 10.1016/j.ijmedinf.2020.104204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
134 Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-lundqvist C, Boriani G, Castella M, Dan G, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, Kirchhof P, Kühne M, Aboyans V, Ahlsson A, Balsam P, Bauersachs J, Benussi S, Brandes A, Braunschweig F, Camm AJ, Capodanno D, Casadei B, Conen D, Crijns HJGM, Delgado V, Dobrev D, Drexel H, Eckardt L, Fitzsimons D, Folliguet T, Gale CP, Gorenek B, Haeusler KG, Heidbuchel H, Iung B, Katus HA, Kotecha D, Landmesser U, Leclercq C, Lewis BS, Mascherbauer J, Merino JL, Merkely B, Mont L, Mueller C, Nagy KV, Oldgren J, Pavlović N, Pedretti RFE, Petersen SE, Piccini JP, Popescu BA, Pürerfellner H, Richter DJ, Roffi M, Rubboli A, Scherr D, Schnabel RB, Simpson IA, Shlyakhto E, Sinner MF, Steffel J, Sousa-uva M, Suwalski P, Svetlosak M, Touyz RM, Dagres N, Arbelo E, Bax JJ, Blomström-lundqvist C, Boriani G, Castella M, Dan G, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J, Lettino M, Lip GYH, Pinto FJ, Neil Thomas G, Valgimigli M, Van Gelder IC, Watkins CL, Delassi T, Sisakian HS, Scherr D, Chasnoits A, Pauw MD, Smajić E, Shalganov T, Avraamides P, Kautzner J, Gerdes C, Alaziz AA, Kampus P, Raatikainen P, Boveda S, Papiashvili G, Eckardt L, Vassilikos V, Csanádi Z, Arnar DO, Galvin J, Barsheshet A, Caldarola P, Rakisheva A, Bytyçi I, Kerimkulova A, Kalejs O, Njeim M, Puodziukynas A, Groben L, Sammut MA, Grosu A, Boskovic A, Moustaghfir A, Groot ND, Poposka L, Anfinsen O, Mitkowski PP, Cavaco DM, Siliste C, Mikhaylov EN, Bertelli L, Kojic D, Hatala R, Fras Z, Arribas F, Juhlin T, Sticherling C, Abid L, Atar I, Sychov O, Bates MGD, Zakirov NU; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 2021;42:373-498. [DOI: 10.1093/eurheartj/ehaa612] [Cited by in Crossref: 731] [Cited by in F6Publishing: 1818] [Article Influence: 365.5] [Reference Citation Analysis]
135 Guggilla RK, Sowa PM, Jamiolkowski J, Sinnadurai S, Amin A, Kaminski KA. Effects of neurohormonal antagonists on blood pressure in patients with heart failure with reduced ejection fraction (HFrEF): a systematic review protocol. Syst Rev 2020;9:194. [PMID: 32838804 DOI: 10.1186/s13643-020-01452-0] [Reference Citation Analysis]
136 Migliavaca CB, Stein C, Colpani V, Eibel B, Bgeginski R, Simões MV, Rohde LE, Falavigna M. High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis. Open Heart 2020;7:e001228. [PMID: 32820054 DOI: 10.1136/openhrt-2019-001228] [Reference Citation Analysis]
137 McIntyre WF, Belesiotis P, McClure GR, Demers C, Chahill G, Hayes A, Sohi G, Bordman W, Whitlock RP, Belley-Côté EP. Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure. Cardiovasc Drugs Ther 2021;35:1009-23. [PMID: 32803405 DOI: 10.1007/s10557-020-07046-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Jarjour M, Henri C, de Denus S, Fortier A, Bouabdallaoui N, Nigam A, O'Meara E, Ahnadi C, White M, Garceau P, Racine N, Parent MC, Liszkowski M, Giraldeau G, Rouleau JL, Ducharme A. Care Gaps in Adherence to Heart Failure Guidelines: Clinical Inertia or Physiological Limitations? JACC Heart Fail 2020;8:725-38. [PMID: 32800509 DOI: 10.1016/j.jchf.2020.04.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
139 Constantinou P, Pelletier-Fleury N, Olié V, Gastaldi-Ménager C, JuillÈre Y, Tuppin P. Patient stratification for risk of readmission due to heart failure by using nationwide administrative data. J Card Fail 2021;27:266-76. [PMID: 32801005 DOI: 10.1016/j.cardfail.2020.07.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Walthall H, Roberts C, Butcher D, Schutz S. Patients' experiences of attending an adapted cardiac rehabilitation programme for heart failure in a day hospice. Int J Palliat Nurs 2020;26:292-300. [PMID: 32841075 DOI: 10.12968/ijpn.2020.26.6.292] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
141 O'Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D'Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. Can J Cardiol 2020;36:159-69. [PMID: 32036861 DOI: 10.1016/j.cjca.2019.11.036] [Cited by in Crossref: 36] [Cited by in F6Publishing: 52] [Article Influence: 18.0] [Reference Citation Analysis]
142 Masarone D, Melillo E, Valente F, Petraio A, Limongelli G, Verrengia M, Gravino R, Ammendola E, D'Alterio G, Vastarella R, Pacileo G. Use of sacubitril/valsartan as 'bridge to transplant' in patients with end-stage hypertrophic cardiomyopathy. Future Cardiol 2021;17:89-94. [PMID: 32723181 DOI: 10.2217/fca-2020-0048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Walther CP, Triozzi JL, Deswal A. Iron deficiency and iron therapy in heart failure and chronic kidney disease. Curr Opin Nephrol Hypertens 2020;29:508-14. [PMID: 32701598 DOI: 10.1097/MNH.0000000000000630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Surikova J, Payne A, Miller KL, Ravaei A, Nolan RP. A cultural and gender-based approach to understanding patient adjustment to chronic heart failure. Health Qual Life Outcomes 2020;18:238. [PMID: 32682424 DOI: 10.1186/s12955-020-01482-1] [Reference Citation Analysis]
145 Akinola S, da Silveira CG, Corbin S, Lavallée M, Thibault M, Gonella J, Gimenes FRE, Leclerc J. Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study. Pharmaceut Med 2020;34:263-9. [PMID: 32671791 DOI: 10.1007/s40290-020-00345-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
146 Ramirez FD. Sex Differences in Cardiac Resynchronization Therapy Device Implantations and Complications: Tough Questions, Tougher Answers. Can J Cardiol 2021;37:14-6. [PMID: 32619450 DOI: 10.1016/j.cjca.2020.03.019] [Reference Citation Analysis]
147 Beldhuis IE, Myhre PL, Claggett B, Damman K, Fang JC, Lewis EF, O'Meara E, Pitt B, Shah SJ, Voors AA, Pfeffer MA, Solomon SD, Desai AS. Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease. JACC Heart Fail. 2019;7:25-32. [PMID: 30606484 DOI: 10.1016/j.jchf.2018.10.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
148 Sotirakos S, Wheen P, Spiers J, Armstrong R. New pharmacotherapy for heart failure with reduced ejection fraction. Expert Rev Cardiovasc Ther. 2020;18:405-414. [PMID: 32546023 DOI: 10.1080/14779072.2020.1784007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
149 Howlett JG, Sharma N, Alemayehu WG, Dyck JRB, Anderson T, Fine N, Becker H, White JA, Paterson DI, Thompson RB, Oudit GY, Haykowsky MJ, Ezekowitz JA. Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction. ESC Heart Fail 2020;7:2725-33. [PMID: 32592541 DOI: 10.1002/ehf2.12863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
150 Keshavarz-Bahaghighat H, Darwesh AM, Sosnowski DK, Seubert JM. Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids. Cells 2020;9:E1565. [PMID: 32604981 DOI: 10.3390/cells9071565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
151 Chow BJW, Coyle D, Hossain A, Laine M, Hanninen H, Ukkonen H, Rajda M, Larose E, Hartikainen J, Mielniczuk L, Kass M, Connelly KA, O'Meara E, Garrard L, Bishop H, Small G, Hedman M, Coyle K, Yla-Herttuala S, Knuuti J, Wells GA, Beanlands RS; IMAGE-HF Investigators. Computed tomography coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE-HF 1C). Eur Heart J Cardiovasc Imaging 2021;22:1083-90. [PMID: 32588042 DOI: 10.1093/ehjci/jeaa109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
152 Ko DR, Beom J, Lee HS, You JS, Chung HS, Chung SP. Benefits of High-Flow Nasal Cannula Therapy for Acute Pulmonary Edema in Patients with Heart Failure in the Emergency Department: A Prospective Multi-Center Randomized Controlled Trial. J Clin Med 2020;9:E1937. [PMID: 32575829 DOI: 10.3390/jcm9061937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
153 Sivakumar B, Malta D, Mak S, Dash S, Newton GE, Arcand J. Evaluating the confounding effects of medical therapies on potassium intake assessment in patients with heart failure. Nutr Metab Cardiovasc Dis 2020;30:1005-13. [PMID: 32265100 DOI: 10.1016/j.numecd.2020.02.010] [Reference Citation Analysis]
154 Tang C, Yin G, Huang C, Wang H, Gao J, Luo J, Zhang Z, Wang J, Hong J, Chai X. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis. Biomed Pharmacother 2020;129:110357. [PMID: 32531679 DOI: 10.1016/j.biopha.2020.110357] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
155 Grant ADM, Chew DS, Howlett JG, Miller RJH. Cost-Effectiveness of Earlier Transition to Angiotensin Receptor Neprilysin Inhibitor in Patients With Heart Failure and Reduced Ejection Fraction. CJC Open 2020;2:447-53. [PMID: 33305203 DOI: 10.1016/j.cjco.2020.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
156 Sabater-Molina M, Navarro-Peñalver M, Muñoz-Esparza C, Esteban-Gil Á, Santos-Mateo JJ, Gimeno JR. Genetic Factors Involved in Cardiomyopathies and in Cancer. J Clin Med 2020;9:E1702. [PMID: 32498335 DOI: 10.3390/jcm9061702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Deyell MW, Abdelwahab A, Angaran P, Essebag V, Glover B, Gula LJ, Khoo C, Lane C, Nault I, Nery PB, Rivard L, Slawnych MP, Tulloch HL, Sapp JL. 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease. Canadian Journal of Cardiology 2020;36:822-36. [DOI: 10.1016/j.cjca.2020.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
158 Pirzada A, Mokhtar AT, Moeller AD. COVID-19 and Myocarditis: What Do We Know So Far? CJC Open 2020;2:278-85. [PMID: 32691024 DOI: 10.1016/j.cjco.2020.05.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 55] [Article Influence: 20.5] [Reference Citation Analysis]
159 Virani SA, Clarke B, Ducharme A, Ezekowitz JA, Heckman GA, McDonald M, Mielniczuk LM, Swiggum E, Van Spall HGC, Zieroth S; Canadian Heart Failure Society. Optimizing Access to Heart Failure Care in Canada During the COVID-19 Pandemic. Can J Cardiol 2020;36:1148-51. [PMID: 32405146 DOI: 10.1016/j.cjca.2020.05.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
160 Mohamed MO, Contractor T, Zachariah D, van Spall HGC, Parwani P, Minissian MB, Rashid M, Martin GP, Barker D, Patwala A, Mamas MA. Sex Disparities in the Choice of Cardiac Resynchronization Therapy Device: An Analysis of Trends, Predictors, and Outcomes. Can J Cardiol 2021;37:86-93. [PMID: 32376344 DOI: 10.1016/j.cjca.2020.02.073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
161 Jung RG, Parlow S, Simard T, Chen C, Ghataura H, Kishore A, Perera A, Moreland R, Hughes I, Tavella R, Hibbert B, Beltrame J, Singh K. Clinical features, sex differences and outcomes of myocardial infarction with nonobstructive coronary arteries: a registry analysis. Coron Artery Dis 2021;32:10-6. [PMID: 32379074 DOI: 10.1097/MCA.0000000000000903] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
162 McGuinty C, Leong D, Weiss A, MacIver J, Kaya E, Hurlburt L, Billia F, Ross H, Wentlandt K. Heart Failure: A Palliative Medicine Review of Disease, Therapies, and Medications With a Focus on Symptoms, Function, and Quality of Life. J Pain Symptom Manage 2020;59:1127-1146.e1. [PMID: 31866489 DOI: 10.1016/j.jpainsymman.2019.12.357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Leclerc J, Blais C, Rochette L, Hamel D, Guénette L, Beaudoin C, Poirier P. Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers. Drugs R D 2020;20:135-45. [PMID: 32342284 DOI: 10.1007/s40268-020-00307-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Haddad H, Bergeron S, Ignaszewski A, Searles G, Rochdi D, Dhage P, Bastien N. Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study. CJC Open 2020;2:344-53. [PMID: 32995719 DOI: 10.1016/j.cjco.2020.04.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
165 Planinc I, Milicic D, Cikes M. Telemonitoring in Heart Failure Management. Card Fail Rev 2020;6:e06. [PMID: 32377385 DOI: 10.15420/cfr.2019.12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
166 Verma S, Sharma A, Kanumilli N, Butler J. Predictors of heart failure development in type 2 diabetes: a practical approach. Curr Opin Cardiol 2019;34:578-83. [PMID: 31219877 DOI: 10.1097/HCO.0000000000000647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
167 Semsar-Kazerooni K, Dima D, Valiquette J, Berube-Dufour J, Goldfarb M. Early Mobilization in People With Acute Cardiovascular Disease. Can J Cardiol 2021;37:232-40. [PMID: 32739452 DOI: 10.1016/j.cjca.2020.03.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
168 Miller RJH, Moayedi Y, Sharma A, Haddad F, Hiesinger W, Banerjee D. Transplant Outcomes in Destination Therapy Left Ventricular Assist Device Patients. ASAIO Journal 2020;66:394-8. [DOI: 10.1097/mat.0000000000001016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
169 Sessa M, Rasmussen DB, Jensen MT, Kragholm K, Torp-Pedersen C, Andersen M. Metoprolol Versus Carvedilol in Patients With Heart Failure, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, and Renal Failure. Am J Cardiol 2020;125:1069-76. [PMID: 32000982 DOI: 10.1016/j.amjcard.2019.12.048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
170 Shuvy M, Zwas DR, Lotan C, Keren A, Gotsman I. Albuminuria: Associated With Heart Failure Severity and Impaired Clinical Outcomes. Canadian Journal of Cardiology 2020;36:527-34. [DOI: 10.1016/j.cjca.2019.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
171 Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, Iliou MC, Pedretti RF, Schmid JP, Vigorito C, Voller H, Wilhelm M, Piepoli MF, Bjarnason-Wehrens B, Berger T, Cohen-Solal A, Cornelissen V, Dendale P, Doehner W, Gaita D, Gevaert AB, Kemps H, Kraenkel N, Laukkanen J, Mendes M, Niebauer J, Simonenko M, Zwisler AO. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2020;:2047487320913379. [PMID: 32223332 DOI: 10.1177/2047487320913379] [Cited by in Crossref: 68] [Cited by in F6Publishing: 130] [Article Influence: 34.0] [Reference Citation Analysis]
172 Ghafourian K, Shapiro JS, Goodman L, Ardehali H. Iron and Heart Failure: Diagnosis, Therapies, and Future Directions. JACC Basic Transl Sci 2020;5:300-13. [PMID: 32215351 DOI: 10.1016/j.jacbts.2019.08.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
173 Sezgin M, Rabuş MB, Selçuk E, Altaş Ö, Sarıkaya S, Balkanay M, Kırali MK. The analysis of unplanned readmissions after left ventricular assist device implantation as bridge-to-transplant. Turk Gogus Kalp Damar Cerrahisi Derg 2020;28:55-62. [PMID: 32175143 DOI: 10.5606/tgkdc.dergisi.2020.18836] [Reference Citation Analysis]
174 Virani SA, Zieroth S, Bray S, Ducharme A, Harkness K, Koshman SL, McDonald M, O'Meara E, Swiggum E, Chan M, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Lepage S, Mielniczuk L, Moe GW, Toma M, Abrams H, Al-Hesaye A, Cohen-Solal A, D'Astous M, De S, Delgado D, Desplantie O, Estrella-Holder E, Green L, Haddad H, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, Matteau S, McKelvie R, Parent MC, Rajda M, Ross HJ, Sussex B; Writing Group., Canadian Heart Failure Society and the Canadian Cardiovascular Society Heart Failure Guidelines Panel; CCS HF Guidelines Primary and Secondary Panel. The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey. CJC Open 2020;2:151-60. [PMID: 32462129 DOI: 10.1016/j.cjco.2020.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
175 Liu T, Quasinowski B, Soares A. The Emulation and Adaptation of a Global Model of Clinical Practice Guidelines on Chronic Heart Failure in BRICS Countries: A Comparative Study. Int J Environ Res Public Health 2020;17:E1735. [PMID: 32155868 DOI: 10.3390/ijerph17051735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
176 Santiago de Araújo Pio C, Beckie TM, Varnfield M, Sarrafzadegan N, Babu AS, Baidya S, Buckley J, Chen S, Gagliardi A, Heine M, Khiong JS, Mola A, Radi B, Supervia M, Trani MR, Abreu A, Sawdon JA, Moffatt PD, Grace SL. Promoting Patient Utilization of Outpatient Cardiac Rehabilitation: A JOINT INTERNATIONAL COUNCIL AND CANADIAN ASSOCIATION OF CARDIOVASCULAR PREVENTION AND REHABILITATION POSITION STATEMENT. Journal of Cardiopulmonary Rehabilitation and Prevention 2020;40:79-86. [DOI: 10.1097/hcr.0000000000000474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
177 Henin M, Ragy H, Mannion J, David S, Refila B, Boles U. Indications of Cardiac Resynchronization in Non-Left Bundle Branch Block: Clinical Review of Available Evidence. Cardiol Res 2020;11:1-8. [PMID: 32095190 DOI: 10.14740/cr989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
178 Freitas C, Wang X, Ge Y, Ross HJ, Austin PC, Pang PS, Ko DT, Farkouh ME, Stukel TA, McMurray JJV, Lee DS. Comparison of Troponin Elevation, Prior Myocardial Infarction, and Chest Pain in Acute Ischemic Heart Failure. CJC Open 2020;2:135-44. [PMID: 32462127 DOI: 10.1016/j.cjco.2020.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
179 Norris CM, Yip CYY, Nerenberg KA, Clavel MA, Pacheco C, Foulds HJA, Hardy M, Gonsalves CA, Jaffer S, Parry M, Colella TJF, Dhukai A, Grewal J, Price JAD, Levinsson ALE, Hart D, Harvey PJ, Van Spall HGC, Sarfi H, Sedlak TL, Ahmed SB, Baer C, Coutinho T, Edwards JD, Green CR, Kirkham AA, Srivaratharajah K, Dumanski S, Keeping-Burke L, Lappa N, Reid RD, Robert H, Smith G, Martin-Rhee M, Mulvagh SL. State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender. J Am Heart Assoc 2020;9:e015634. [PMID: 32063119 DOI: 10.1161/JAHA.119.015634] [Cited by in Crossref: 20] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
180 Ware P, Ross HJ, Cafazzo JA, Boodoo C, Munnery M, Seto E. Outcomes of a Heart Failure Telemonitoring Program Implemented as the Standard of Care in an Outpatient Heart Function Clinic: Pretest-Posttest Pragmatic Study. J Med Internet Res 2020;22:e16538. [PMID: 32027309 DOI: 10.2196/16538] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
181 Romanò M. Barriers to Early Utilization of Palliative Care in Heart Failure: A Narrative Review. Healthcare (Basel) 2020;8:E36. [PMID: 32046146 DOI: 10.3390/healthcare8010036] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
182 Boscart V, Crutchlow LE, Sheiban Taucar L, Johnson K, Heyer M, Davey M, Costa AP, Heckman G. Chronic disease management models in nursing homes: a scoping review. BMJ Open 2020;10:e032316. [PMID: 32029485 DOI: 10.1136/bmjopen-2019-032316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
183 Rørth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, Køber L, Prescott MF, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, Mcmurray JJ. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Circ: Heart Failure 2020;13. [DOI: 10.1161/circheartfailure.119.006541] [Cited by in Crossref: 17] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
184 Okutucu S, Sabanoglu C, Yetis Sayin B, Aksoy H, Bursa N, Oto A. Switching from ramipril to sacubitril/valsartan favorably alters electrocardiographic indices of ventricular repolarization in heart failure with reduced ejection fraction. Acta Cardiol 2020;75:20-5. [PMID: 30513267 DOI: 10.1080/00015385.2018.1535818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
185 Huitema AA, Harkness K, Malik S, Suskin N, Mckelvie RS. Therapies for Advanced Heart Failure Patients Ineligible for Heart Transplantation: Beyond Pharmacotherapy. Canadian Journal of Cardiology 2020;36:234-43. [DOI: 10.1016/j.cjca.2019.11.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
186 Uz İ, Kiyan GS, ÖzÇete E, YalÇinli S, Korgan MB, Altunci YA, Ersel M, Akarca FK, Yavuzgİl O. Is the flow-safe disposable continuous positive airway pressure (CPAP) system as effective as non-invasive mechanical ventilation (NIMV) in the treatment of acute cardiogenic pulmonary Oedema? Am J Emerg Med 2021;39:109-13. [PMID: 31983599 DOI: 10.1016/j.ajem.2020.01.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Yang Y, Xu C, Tang S, Xia Z. Interleukin-9 Aggravates Isoproterenol-Induced Heart Failure by Activating Signal Transducer and Activator of Transcription 3 Signalling. Can J Cardiol 2020;36:1770-81. [PMID: 32621886 DOI: 10.1016/j.cjca.2020.01.011] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
188 Kalogeropoulos A, Papadimitriou L, Georgiopoulou VV, Dunbar SB, Skopicki H, Butler J. Low- Versus Moderate-Sodium Diet in Patients With Recent Hospitalization for Heart Failure: The PROHIBIT (Prevent Adverse Outcomes in Heart Failure by Limiting Sodium) Pilot Study. Circ Heart Fail 2020;13:e006389. [PMID: 31959014 DOI: 10.1161/CIRCHEARTFAILURE.119.006389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
189 Boa Sorte Silva NC, Pulford RW, Lee DS, Petrella RJ. Heart failure management insights from primary care physicians and allied health care providers in Southwestern Ontario. BMC Fam Pract 2020;21:8. [PMID: 31931728 DOI: 10.1186/s12875-020-1080-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
190 Khan MS, Jones DW, Butler J. Salt, No Salt, or Less Salt for Patients With Heart Failure? Am J Med 2020;133:32-8. [PMID: 31419422 DOI: 10.1016/j.amjmed.2019.07.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
191 Alfraidi H, Seifer CM, Hiebert BM, Torbiak L, Zieroth S, McIntyre WF. Relation of Increasing QRS Duration Over Time and Cardiovascular Events in Outpatients With Heart Failure. Am J Cardiol 2019;124:1907-11. [PMID: 31668343 DOI: 10.1016/j.amjcard.2019.09.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
192 Im J, Mak S, Upshur R, Steinberg L, Kuluski K. "Whatever happens, happens" challenges of end-of-life communication from the perspective of older adults and family caregivers: a Qualitative study. BMC Palliat Care 2019;18:113. [PMID: 31830967 DOI: 10.1186/s12904-019-0493-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
193 Al-Jarallah M, Rajan R, Al-Zakwani I, Dashti R, Bulbanat B, Ridha M, Sulaiman K, Alsheikh-Ali AA, Panduranga P, AlHabib KF, Al Suwaidi J, Al-Mahmeed W, AlFaleh H, Elasfar A, Al-Motarreb A, Bazargani N, Asaad N, Amin H. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction. ESC Heart Fail 2020;7:297-305. [PMID: 31825180 DOI: 10.1002/ehf2.12538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
194 Sharma S, Thomas SS. Management of Heart Failure and Cardiogenic Shock in Pregnancy. Curr Treat Options Cardiovasc Med 2019;21:83. [PMID: 31820124 DOI: 10.1007/s11936-019-0797-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
195 Colin-Ramirez E, Arcand J, Woo E, Brum M, Morgan K, Christopher W, Velázquez L, Sharifzad A, Feeney S, Ezekowitz JA. Design and Region-Specific Adaptation of the Dietary Intervention Used in the SODIUM-HF Trial: A Multicentre Study. CJC Open 2020;2:8-14. [PMID: 32159131 DOI: 10.1016/j.cjco.2019.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
196 Diamant MJ, Toma M. Should We Be Using Sex-Specific Heart Failure Risk Scores? Can J Cardiol 2020;36:11-2. [PMID: 31787437 DOI: 10.1016/j.cjca.2019.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
197 Goyder CR, Roalfe AK, Jones NR, Taylor KS, Plumptre CD, Fanshawe TR, Hobbs FDR, Taylor CJ. Diagnostic accuracy and clinical impact of natriuretic peptide screening for the detection of heart failure in the community: a protocol for systematic review and meta-analysis. Wellcome Open Res 2019;4:169. [DOI: 10.12688/wellcomeopenres.15536.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Kaufmann D, Szwoch M, Kwiatkowska J, Raczak G, Daniłowicz-Szymanowicz L. Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction. PLoS One 2019;14:e0225829. [PMID: 31790492 DOI: 10.1371/journal.pone.0225829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
199 Liu Z, Wang J, Li Y. Efficacy of sacubitril valsartan sodium tablet for the treatment of chronic heart failure: A systematic review protocol of randomized controlled trials. Medicine (Baltimore) 2019;98:e18050. [PMID: 31764831 DOI: 10.1097/MD.0000000000018050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
200 Noly PE, Pagani FD, Noiseux N, Stulak JM, Khalpey Z, Carrier M, Maltais S. Continuous-Flow Left Ventricular Assist Devices and Valvular Heart Disease: A Comprehensive Review. Can J Cardiol 2020;36:244-60. [PMID: 32036866 DOI: 10.1016/j.cjca.2019.11.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
201 Shirakabe A, Asai K, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, Goda H, Shigihara S, Asano K, Tani K, Kiuchi K, Hata N, Shimizu W. Prognostic Value of Both Plasma Volume Status and Nutritional Status in Patients With Severely Decompensated Acute Heart Failure. CJC Open 2019;1:305-15. [PMID: 32159125 DOI: 10.1016/j.cjco.2019.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Lotierzo M, Dupuy AM, Kalmanovich E, Roubille F, Cristol JP. sST2 as a value-added biomarker in heart failure. Clin Chim Acta 2020;501:120-30. [PMID: 31678574 DOI: 10.1016/j.cca.2019.10.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
203 Sheng K, Nie Y, Gao B. Recent advances in myocardial regeneration strategy. J Int Med Res 2019;47:5453-64. [PMID: 31640440 DOI: 10.1177/0300060519862663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
204 Sharma A, Ezekowitz JA. Role of Sodium-Glucose Cotransporter-2 Inhibition in the Treatment of Adults With Heart Failure. Can J Diabetes 2020;44:103-10. [PMID: 31630988 DOI: 10.1016/j.jcjd.2019.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
205 Nguyen Q, Wang K, Nikhanj A, Chen-Song D, DeKock I, Ezekowitz J, Mirhosseini M, Cujec B, Oudit GY. Screening and Initiating Supportive Care in Patients With Heart Failure. Front Cardiovasc Med 2019;6:151. [PMID: 31696120 DOI: 10.3389/fcvm.2019.00151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
206 Sweeney C, Ryan F, Ledwidge M, Ryan C, McDonald K, Watson C, Pharithi RB, Gallagher J. Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure. Cochrane Database Syst Rev 2019;10:CD013015. [PMID: 31613983 DOI: 10.1002/14651858.CD013015.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
207 Bouabdallaoui N, O'Meara E, Bernier V, Komajda M, Swedberg K, Tavazzi L, Borer JS, Bohm M, Ford I, Tardif JC. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m. ESC Heart Fail 2019;6:1199-207. [PMID: 31591826 DOI: 10.1002/ehf2.12513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
208 Kiamanesh O, Kaan A, Toma M. Medical Management of Left Ventricular Assist Device Patients: A Practical Guide for the Nonexpert Clinician. Can J Cardiol 2020;36:205-15. [PMID: 31879052 DOI: 10.1016/j.cjca.2019.09.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
209 Luc JG, Hong JC, Cheung AW, Cook RC, Skarsgard PL, Ye J, Nguyen TC. The MITRA-FR Trial Vs the COAPT Trial: More Complementary Than Contradictory? The Annals of Thoracic Surgery 2019;108:965-8. [DOI: 10.1016/j.athoracsur.2019.04.083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
210 Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. CMAJ 2018;190:E1192-206. [PMID: 30301743 DOI: 10.1503/cmaj.180194] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
211 Im J, Mak S, Upshur R, Steinberg L, Kuluski K. 'The Future is Probably Now': Understanding of illness, uncertainty and end-of-life discussions in older adults with heart failure and family caregivers. Health Expect 2019;22:1331-40. [PMID: 31560824 DOI: 10.1111/hex.12980] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
212 James M, Manns B. Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease. Circulation 2018;138:1515-8. [PMID: 30354525 DOI: 10.1161/CIRCULATIONAHA.118.036523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
213 Sun LY, Tu JV, Coutinho T, Turek M, Rubens FD, McDonnell L, Tulloch H, Eddeen AB, Mielniczuk LM. Sex differences in outcomes of heart failure in an ambulatory, population-based cohort from 2009 to 2013. CMAJ 2018;190:E848-54. [PMID: 30012800 DOI: 10.1503/cmaj.180177] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
214 Beique LC, Ezekowitz JA, O'Meara E, McDonald M, Koshman SL. 2017 Guidelines for the management of heart failure by pharmacists. Can Pharm J (Ott) 2019;152:301-16. [PMID: 31534586 DOI: 10.1177/1715163519853307] [Reference Citation Analysis]
215 Floras JS. Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor. Circ Res 2018;122:1741-64. [PMID: 29880501 DOI: 10.1161/CIRCRESAHA.118.310783] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 28.3] [Reference Citation Analysis]
216 Schulz M, Griese‐mammen N, Böhm M, Laufs U. Letter on ‘Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial’: reply. Eur J Heart Fail 2020;22:565-6. [DOI: 10.1002/ejhf.1613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
217 Janaudis-ferreira T, Mathur S, Deliva R, Howes N, Patterson C, Räkel A, So S, Wickerson L, White M, Avitzur Y, Johnston O, Heywood N, Singh S, Holdsworth S. Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation and CAN-RESTORE. Transplantation 2019;103:e220-38. [DOI: 10.1097/tp.0000000000002806] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
218 Sobanski PZ, Alt-epping B, Currow DC, Goodlin SJ, Grodzicki T, Hogg K, Janssen DJA, Johnson MJ, Krajnik M, Leget C, Martínez-sellés M, Moroni M, Mueller PS, Ryder M, Simon ST, Stowe E, Larkin PJ. Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement. Cardiovascular Research 2020;116:12-27. [DOI: 10.1093/cvr/cvz200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
219 Vishram-Nielsen JKK, Foroutan F, Ross HJ, Gustafsson F, Alba AC. Performance of Prognostic Risk Scores in Heart Failure Patients: Do Sex Differences Exist? Can J Cardiol 2020;36:45-53. [PMID: 31874750 DOI: 10.1016/j.cjca.2019.08.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
220 Prince SA, Wooding E, Mielniczuk L, Pipe AL, Chan K, Keast M, Harris J, Tulloch HE, Mark AE, Cotie LM, Wells GA, Reid RD. Nordic walking and standard exercise therapy in patients with chronic heart failure: A randomised controlled trial comparison. Eur J Prev Cardiolog 2019;26:1790-4. [DOI: 10.1177/2047487319871215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Bouabdallaoui N, Ducharme A. Setting Up a Heart Failure Program in 2018: Moving Towards New Paradigm(s). Curr Heart Fail Rep 2018;15:357-67. [PMID: 30251188 DOI: 10.1007/s11897-018-0412-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
222 Myhre PL, O'Meara E, Claggett BL, de Denus S, Jarolim P, Anand IS, Beldhuis IE, Fleg JL, Lewis E, Pitt B, Rouleau JL, Solomon SD, Pfeffer MA, Desai AS. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction. Circ Heart Fail 2018;11:e005312. [PMID: 30571192 DOI: 10.1161/CIRCHEARTFAILURE.118.005312] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
223 Chuzi S, Allen LA, Dunlay SM, Warraich HJ. Palliative Inotrope Therapy: A Narrative Review. JAMA Cardiol 2019;4:815. [DOI: 10.1001/jamacardio.2019.2081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
224 Kandolin RM, Wiefels CC, Mesquita CT, Chong A, Boland P, Glineur D, Sun L, Beanlands RS, Mielniczuk LM. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function. Canadian Journal of Cardiology 2019;35:1015-29. [DOI: 10.1016/j.cjca.2019.04.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
225 Loai S, Cheng HM. Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging. Heart Fail Rev 2020;25:305-19. [DOI: 10.1007/s10741-019-09836-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
226 Crossland DS, Van De Bruaene A, Silversides CK, Hickey EJ, Roche SL. Heart Failure in Adult Congenital Heart Disease: From Advanced Therapies to End-of-Life Care. Can J Cardiol 2019;35:1723-39. [PMID: 31813505 DOI: 10.1016/j.cjca.2019.07.626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
227 Buchan TA, Ross HJ, McDonald M, Billia F, Delgado D, Duero Posada JG, Luk A, Guyatt GH, Alba AC. Physician Judgement vs Model-Predicted Prognosis in Patients With Heart Failure. Can J Cardiol 2020;36:84-91. [PMID: 31735429 DOI: 10.1016/j.cjca.2019.07.623] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
228 Chiu MH, Howlett JG, Sharma NC. Initiation of ivabradine in cardiogenic shock. ESC Heart Fail 2019;6:1088-91. [PMID: 31332966 DOI: 10.1002/ehf2.12499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
229 McLellan J, Bankhead CR, Oke JL, Hobbs FDR, Taylor CJ, Perera R. Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis. BMJ Evid Based Med 2020;25:33-7. [PMID: 31326896 DOI: 10.1136/bmjebm-2019-111208] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
230 Santiago de Araújo Pio C, Beckie TM, Varnfield M, Sarrafzadegan N, Babu AS, Baidya S, Buckley J, Chen SY, Gagliardi A, Heine M, Khiong JS, Mola A, Radi B, Supervia M, Trani MR, Abreu A, Sawdon JA, Moffatt PD, Grace SL. Promoting patient utilization of outpatient cardiac rehabilitation: A joint International Council and Canadian Association of Cardiovascular Prevention and Rehabilitation position statement. Int J Cardiol 2020;298:1-7. [PMID: 31405584 DOI: 10.1016/j.ijcard.2019.06.064] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
231 Beattie WS, Yang H. Perioperative beta-adrenergic antagonism: panacea or poison? Br J Anaesth 2019;123:97-100. [PMID: 31248641 DOI: 10.1016/j.bja.2019.05.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
232 Diamant MJ, Virani SA, MacKenzie WJ, Ignaszewski A, Toma M, Hawkins NM. Medical therapy doses at hospital discharge in patients with existing and de novo heart failure. ESC Heart Fail 2019;6:774-83. [PMID: 31218850 DOI: 10.1002/ehf2.12454] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
233 Tremblay-Gravel M, Pacheco C. The Thyroid Axis in Peripartum Cardiomyopathy: A Potential Contributor to a Multifaceted Disease. Can J Cardiol 2019;35:710-1. [PMID: 31151705 DOI: 10.1016/j.cjca.2019.04.019] [Reference Citation Analysis]
234 Sepehrvand N, Alemayehu W, Rowe BH, McAlister FA, van Diepen S, Stickland M, Ezekowitz JA. High vs. low oxygen therapy in patients with acute heart failure: HiLo-HF pilot trial. ESC Heart Fail 2019;6:667-77. [PMID: 31102328 DOI: 10.1002/ehf2.12448] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
235 Nikolaou M, Chrysohoou C, Georgilas TA, Giamouzis G, Giannakoulas G, Karavidas A, Papadopoulos C, Patsilinakos S, Tziakas D, Parissis J; Hellenic Iron Consensus Group. Management of iron deficiency in chronic heart failure: Practical considerations for clinical use and future directions. Eur J Intern Med 2019;65:17-25. [PMID: 31109847 DOI: 10.1016/j.ejim.2019.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
236 Baril JF, Bromberg S, Moayedi Y, Taati B, Manlhiot C, Ross HJ, Cafazzo J. Use of Free-Living Step Count Monitoring for Heart Failure Functional Classification: Validation Study. JMIR Cardio 2019;3:e12122. [PMID: 31758777 DOI: 10.2196/12122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
237 Sepehrvand N, Alemayehu W, Dyck GJ, Dyck JR, Anderson T, Howlett J, Paterson I, Mcalister FA, Ezekowitz JA; On behalf of the Alberta HEART Investigators. External Validation of the H 2 F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction. Circulation 2019;139:2377-9. [DOI: 10.1161/circulationaha.118.038594] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
238 Leis B, Frost A, Bryce R, Lyon AW, Coverett K. Altering standard admission order sets to promote clinical laboratory stewardship: a cohort quality improvement study. BMJ Qual Saf 2019;28:846-52. [PMID: 31073090 DOI: 10.1136/bmjqs-2018-008995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
239 Shen L, Jhund PS, Docherty KF, Petrie MC, Anand IS, Carson PE, Desai AS, Granger CB, Komajda M, Mckelvie RS, Pfeffer MA, Solomon SD, Swedberg K, Zile MR, Mcmurray JJ. Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC: Heart Failure 2019;7:418-27. [DOI: 10.1016/j.jchf.2018.12.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
240 Normand C, Kaye DM, Povsic TJ, Dickstein K. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology. Lancet 2019;393:1045-55. [PMID: 30860030 DOI: 10.1016/S0140-6736(18)32216-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
241 Yurista SR, Silljé HH, Oberdorf‐maass SU, Schouten E, Pavez Giani MG, Hillebrands J, van Goor H, van Veldhuisen DJ, de Boer RA, Westenbrink BD. Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction. Eur J Heart Fail 2019;21:862-73. [DOI: 10.1002/ejhf.1473] [Cited by in Crossref: 85] [Cited by in F6Publishing: 132] [Article Influence: 28.3] [Reference Citation Analysis]
242 Yogasundaram H, Chappell MC, Braam B, Oudit GY. Cardiorenal Syndrome and Heart Failure-Challenges and Opportunities. Can J Cardiol 2019;35:1208-19. [PMID: 31300181 DOI: 10.1016/j.cjca.2019.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
243 Berbenetz N, Wang Y, Brown J, Godfrey C, Ahmad M, Vital FM, Lambiase P, Banerjee A, Bakhai A, Chong M. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev. 2019;4:CD005351. [PMID: 30950507 DOI: 10.1002/14651858.cd005351.pub4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
244 Cao Y, He S, Tao Z, Chen W, Xu Y, Liu P, Wang R, Wu J, Li L, Chen X. Macrophage-Specific IκB Kinase α Contributes to Ventricular Remodelling and Dysfunction After Myocardial Infarction. Canadian Journal of Cardiology 2019;35:490-500. [DOI: 10.1016/j.cjca.2019.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
245 AlTurki A, Proietti R, Russo V, Dhanjal T, Banerjee P, Essebag V. Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients. Pharmacol Res 2019;143:133-42. [PMID: 30914300 DOI: 10.1016/j.phrs.2019.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
246 Ghafourian K, Chang H, Ardehali H. Intravenous iron therapy in heart failure: a different perspective. Eur J Heart Fail 2019;21:703-14. [DOI: 10.1002/ejhf.1434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
247 Leon SJ, Harasemiw O, Tangri N. New therapies for hyperkalemia. Curr Opin Nephrol Hypertens 2019;28:238-44. [PMID: 30865167 DOI: 10.1097/MNH.0000000000000500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
248 He R, Ding C, Yin P, He L, Xu Q, Wu Z, Shi Y, Su L. MiR-1a-3p mitigates isoproterenol-induced heart failure by enhancing the expression of mitochondrial ND1 and COX1. Exp Cell Res 2019;378:87-97. [PMID: 30853447 DOI: 10.1016/j.yexcr.2019.03.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
249 Brochu B, Chan M. Treatment of diabetes and heart failure: a paradigm shift for cardiologists? Current Opinion in Cardiology 2019;34:207-12. [DOI: 10.1097/hco.0000000000000599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
250 Du AX, Westerhout CM, Mcalister FA, Shanks M, Oudit GY, Paterson DI, Hanninen M, Thomas J, Ezekowitz JA. Titration and Tolerability of Sacubitril/Valsartan for Patients With Heart Failure in Clinical Practice: . Journal of Cardiovascular Pharmacology 2019;73:149-54. [DOI: 10.1097/fjc.0000000000000643] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
251 Turgeon RD, Kolber MR, Loewen P, Ellis U, McCormack JP. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis. PLoS One 2019;14:e0212907. [PMID: 30817783 DOI: 10.1371/journal.pone.0212907] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
252 Dyck GJB, Raj P, Zieroth S, Dyck JRB, Ezekowitz JA. The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review. Int J Mol Sci 2019;20:E904. [PMID: 30791450 DOI: 10.3390/ijms20040904] [Cited by in Crossref: 46] [Cited by in F6Publishing: 60] [Article Influence: 15.3] [Reference Citation Analysis]
253 Korol S, White M, O'Meara E, Rouleau JL, White-Guay B, Dorais M, Ahmed A, de Denus S, Perreault S. Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure? Eur J Clin Pharmacol 2019;75:837-47. [PMID: 30758517 DOI: 10.1007/s00228-018-02615-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
254 Morris JH, Chen L. Exercise Training and Heart Failure: A Review of the Literature. Card Fail Rev. 2019;5:57-61. [PMID: 30847247 DOI: 10.15420/cfr.2018.31.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
255 Manolis AS, Manolis TA, Manolis AA, Melita H. Neprilysin Inhibitors: Filling a Gap in Heart Failure Management, Albeit Amidst Controversy and at a Significant Cost. Am J Cardiovasc Drugs 2019;19:21-36. [PMID: 29926350 DOI: 10.1007/s40256-018-0289-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
256 Fu WB, Wang WE, Zeng CY. Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol Sin 2019;40:9-12. [PMID: 30002488 DOI: 10.1038/s41401-018-0060-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
257 Kushneriuk D, Haddad H, Basran R, Shavadia JS. Secondary mitral regurgitation: percutaneous edge-to-edge repair on the cutting edge? Curr Opin Cardiol 2019;34:185-93. [PMID: 30575648 DOI: 10.1097/HCO.0000000000000593] [Reference Citation Analysis]
258 Moayedi Y, Etchells E, Kobulnik J, Ross H. Brain natriuretic peptide and shortness of breath in the emergency department. CMAJ 2018;190:E1361-3. [PMID: 30455271 DOI: 10.1503/cmaj.170770] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
259 Colin-Ramirez E, Ezekowitz JA; SODIUM-HF investigators. Rationale and design of the Study of Dietary Intervention Under 100 MMOL in Heart Failure (SODIUM-HF). Am Heart J 2018;205:87-96. [PMID: 30205241 DOI: 10.1016/j.ahj.2018.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
260 Raymond-paquin A, Nattel S, Wakili R, Tadros R. Mechanisms and Clinical Significance of Arrhythmia-Induced Cardiomyopathy. Canadian Journal of Cardiology 2018;34:1449-60. [DOI: 10.1016/j.cjca.2018.07.475] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
261 Savvoulidis P, Butler J, Kalogeropoulos A. Cardiomyopathy and Heart Failure in Patients With HIV Infection. Can J Cardiol 2019;35:299-309. [PMID: 30621958 DOI: 10.1016/j.cjca.2018.10.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
262 Chiu MH, Miller RJH, Barry R, Li B, Har BJ, Wilton SB, Knudtson M, Howlett JG, James MT. Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study. Can J Kidney Health Dis 2018;5:2054358118804838. [PMID: 30349729 DOI: 10.1177/2054358118804838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
263 McCudden CR. Quality, origins and limitations of common therapeutic drug reference intervals. Diagnosis (Berl) 2018;5:47-61. [PMID: 29794249 DOI: 10.1515/dx-2018-0001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
264 Westphal JG, Bekfani T, Schulze PC. What’s new in heart failure therapy 2018?†. Interactive CardioVascular and Thoracic Surgery 2018;27:921-30. [DOI: 10.1093/icvts/ivy282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
265 Mancini GBJ, Cheng AY, Connelly K, Fitchett D, Goldenberg R, Goodman S, Leiter LA, Lonn E, Paty B, Poirier P, Stone J, Thompson D, Verma S, Woo V, Yale J. CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management. Canadian Journal of Cardiology 2018;34:1350-61. [DOI: 10.1016/j.cjca.2018.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
266 Connelly KA, Gilbert RE, Liu P; Diabetes Canada Clinical Practice Guidelines Expert Committee. Treatment of Diabetes in People With Heart Failure. Can J Diabetes 2018;42 Suppl 1:S196-200. [PMID: 29650096 DOI: 10.1016/j.jcjd.2017.10.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
267 Sirois C, Lunghi C, Laroche ML, Maheux A, Frini A. The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey. Res Social Adm Pharm 2019;15:761-6. [PMID: 30249377 DOI: 10.1016/j.sapharm.2018.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
268 Zuzarte P, Scola G, Duong A, Kostiw K, Figueira ML, Costa-vitali A. NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure. Journal of Psychiatric Research 2018;104:8-15. [DOI: 10.1016/j.jpsychires.2018.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
269 Sidhu RS, Tyrrell BD, Welsh RC, Meyer SR, Shanks M, Bainey KR. Transcatheter Mitral Valve Intervention for Chronic Mitral Regurgitation: A Plethora of Different Technologies. Canadian Journal of Cardiology 2018;34:1200-9. [DOI: 10.1016/j.cjca.2018.04.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
270 Cho MS, Kim M, Lee SE, Choi H, Lee J, Cho H, Lee H, Choi J, Jeon E, Hwang K, Chae SC, Baek SH, Kang S, Choi D, Yoo B, Ahn Y, Kim K, Park H, Cho M, Oh B, Kim J. Outcomes After Predischarge Initiation of β-Blocker in Patients Hospitalized for Severe Decompensated Heart Failure Requiring Inotropic Therapy. Canadian Journal of Cardiology 2018;34:1145-52. [DOI: 10.1016/j.cjca.2018.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
271 Andries G, Yandrapalli S, Aronow WS. Benefit–risk review of different drug classes used in chronic heart failure. Expert Opinion on Drug Safety 2019;18:37-49. [DOI: 10.1080/14740338.2018.1512580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
272 Llano A, Mckay G. The treatment of type 2 diabetes in heart failure. Pract Diab 2018;35:123-6. [DOI: 10.1002/pdi.2178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
273 Skanes AC, Tang ASL. Atrial Fibrillation and Heart Failure: Untangling a Modern Gordian Knot. Can J Cardiol 2018;34:1437-48. [PMID: 30404749 DOI: 10.1016/j.cjca.2018.07.483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
274 Ho JE. β-Blockers After Inotropes in Acute Heart Failure-When Is the Right Time? Can J Cardiol 2018;34:1102-3. [PMID: 30033081 DOI: 10.1016/j.cjca.2018.06.002] [Reference Citation Analysis]
275 Rush B, Walley KR. The Emerging Role of Palliative Care in the Management of Canadians With Heart Failure. Can J Cardiol 2018;34:1114-5. [PMID: 30093302 DOI: 10.1016/j.cjca.2018.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
276 Huitema AA, Harkness K, Heckman GA, Mckelvie RS. The Spoke-Hub-and-Node Model of Integrated Heart Failure Care. Canadian Journal of Cardiology 2018;34:863-70. [DOI: 10.1016/j.cjca.2018.04.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
277 Ware P, Seto E, Ross HJ. Accounting for Complexity in Home Telemonitoring: A Need for Context-Centred Evidence. Canadian Journal of Cardiology 2018;34:897-904. [DOI: 10.1016/j.cjca.2018.01.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
278 Heckman GA, Shamji AK, Ladha R, Stapleton J, Boscart V, Boxer RS, Martin LB, Crutchlow L, Mckelvie RS. Heart Failure Management in Nursing Homes: A Scoping Literature Review. Canadian Journal of Cardiology 2018;34:871-80. [DOI: 10.1016/j.cjca.2018.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
279 Martin N, Manoharan K, Thomas J, Davies C, Lumbers RT. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database Syst Rev 2018;6:CD012721. [PMID: 29952095 DOI: 10.1002/14651858.CD012721.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
280 Yandrapalli S, Khan MH, Rochlani Y, Aronow WS. Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy. Ther Adv Cardiovasc Dis 2018;12:217-31. [PMID: 29921166 DOI: 10.1177/1753944718784536] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
281 Kusunose K, Seno H, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M. Right Ventricular Function and Beneficial Effects of Cardiac Rehabilitation in Patients With Systolic Chronic Heart Failure. Can J Cardiol 2018;34:1307-15. [PMID: 30146462 DOI: 10.1016/j.cjca.2018.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
282 Pilkey J, Pedersen A, Tam JW, Malik A, Wong J. The Use of Intranasal Fentanyl for the Palliation of Incident Dyspnea in Advanced Congestive Heart Failure: A Pilot Study. J Palliat Care 2019;34:96-102. [DOI: 10.1177/0825859718777343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
283 Bakalakos A, Ritsatos K, Anastasakis A. Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view. Hellenic J Cardiol 2018;59:254-61. [PMID: 29807197 DOI: 10.1016/j.hjc.2018.05.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
284 Girelli D, Marchi G, Camaschella C. Anemia in the Elderly. Hemasphere 2018;2:e40. [PMID: 31723768 DOI: 10.1097/HS9.0000000000000040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
285 Slawnych M. New Dimensions in Palliative Care Cardiology. Can J Cardiol 2018;34:914-24. [PMID: 29960618 DOI: 10.1016/j.cjca.2018.03.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
286 Limongelli G, Bossone E, Elliott PM, Day SM. On the Road from Gene to Therapy in Inherited Cardiomyopathies. Heart Failure Clinics 2018;14:xi-v. [DOI: 10.1016/j.hfc.2018.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
287 Masarone D, Kaski JP, Pacileo G, Elliott PM, Bossone E, Day SM, Limongelli G. Epidemiology and Clinical Aspects of Genetic Cardiomyopathies. Heart Failure Clinics 2018;14:119-28. [DOI: 10.1016/j.hfc.2017.12.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
288 Normand C, Linde C, Singh J, Dickstein K. Indications for Cardiac Resynchronization Therapy. JACC: Heart Failure 2018;6:308-16. [DOI: 10.1016/j.jchf.2018.01.022] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
289 Meagher P, Adam M, Civitarese R, Bugyei-Twum A, Connelly KA. Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management. Can J Cardiol 2018;34:632-43. [PMID: 29731023 DOI: 10.1016/j.cjca.2018.02.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
290 Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Gregoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallee M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Cote AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2018;34:506-525. [PMID: 29731013 DOI: 10.1016/j.cjca.2018.02.022] [Cited by in Crossref: 301] [Cited by in F6Publishing: 330] [Article Influence: 75.3] [Reference Citation Analysis]
291 Almufleh A, Mielniczuk LM, Zinoviev R, Moeller A, Davies RA, Stadnick E, Chan V, Chih S. Profound Vasoplegia During Sacubitril/Valsartan Treatment After Heart Transplantation. Canadian Journal of Cardiology 2018;34:343.e5-7. [DOI: 10.1016/j.cjca.2017.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
292 Heckman GA, Mckelvie RS, Rockwood K. Individualizing the care of older heart failure patients. Current Opinion in Cardiology 2018;33:208-16. [DOI: 10.1097/hco.0000000000000489] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
293 Wiskar K, Toma M, Rush B. Palliative care in heart failure. Trends Cardiovasc Med 2018;28:445-50. [PMID: 29735287 DOI: 10.1016/j.tcm.2018.02.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
294 Girelli D, Ugolini S, Busti F, Marchi G, Castagna A. Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol 2018;107:16-30. [PMID: 29196967 DOI: 10.1007/s12185-017-2373-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 14.8] [Reference Citation Analysis]
295 Wang CC, Wu CK, Tsai ML, Lee CM, Huang WC, Chou HH, Huang JL, Chi NH, Yen HW, Tzeng BH, Chang WT, Chang HY, Wang CH, Lu YY, Tsai JP, Su CH, Cherng WJ, Yin WH, Tsai CT, Wu YW, Lin JL, Hwang JJ. 2019 Focused Update of the Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure. Acta Cardiol Sin 2019;35:244-83. [PMID: 31249457 DOI: 10.6515/ACS.201905_35(3).20190422A] [Cited by in F6Publishing: 15] [Reference Citation Analysis]